SCH708980
SCH708980 is a humanized monoclonal antibody inhibitor targeting IL-10. SCH708980 has anti-immunosuppressive activity. SCH708980 can be used for visceral leishmaniasis, sepsis-associated kidney injury (SAKI) and osteoporosis research[1][2][3].
Product Specifications
UNSPSC
12352100
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
References & Citations
[1]Wang C, et al. Text Mining and Drug Discovery Analysis: A Comprehensive Approach to Investigate Diabetes-Induced Osteoporosis. Int J Med Sci. 2024 Jan 1;21 (3) :464-473.|[2]Sun S, et al. Identification of potential hub genes and drugs in septic kidney injury: a bioinformatic analysis with preliminary experimental validation. Front Med (Lausanne) . 2025 Mar 17;12:1502189. |[3]Vacchelli E, et al. Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 2012 Jul 1;1 (4) :493-506.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IL-10
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2011608-01 0.01 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Sign In for Pricing
View Details MBS2011608-02 0.05 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Sign In for Pricing
View Details MBS2011608-03 0.1 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Sign In for Pricing
View Details MBS2011608-04 0.2 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Sign In for Pricing
View Details MBS2011608-05 0.5 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Sign In for Pricing
View Details MBS2011608-06 1 mg
Recombinant Beta-1,3-N-Acetylglucosaminyltransferase Manic Fringe (MFNG)
Sign In for Pricing
View Details